Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 21 | 2022 | 154 | 10.080 |
Why?
|
| Cochlear Implantation | 18 | 2022 | 99 | 4.880 |
Why?
|
| Cochlear Implants | 23 | 2022 | 110 | 4.650 |
Why?
|
| Hearing Loss, Sensorineural | 11 | 2021 | 110 | 3.620 |
Why?
|
| Skull Base | 8 | 2018 | 72 | 3.560 |
Why?
|
| Speech Perception | 18 | 2022 | 261 | 3.120 |
Why?
|
| Meniere Disease | 4 | 2022 | 31 | 2.730 |
Why?
|
| Eustachian Tube | 7 | 2022 | 31 | 2.210 |
Why?
|
| Ear Diseases | 6 | 2022 | 37 | 2.150 |
Why?
|
| Temporal Bone | 7 | 2019 | 53 | 2.150 |
Why?
|
| Retrospective Studies | 39 | 2022 | 7264 | 1.830 |
Why?
|
| Mastoidectomy | 4 | 2022 | 7 | 1.810 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 4 | 2016 | 15 | 1.730 |
Why?
|
| Osteomyelitis | 3 | 2017 | 40 | 1.700 |
Why?
|
| Child, Preschool | 19 | 2021 | 3185 | 1.690 |
Why?
|
| Internship and Residency | 4 | 2022 | 596 | 1.600 |
Why?
|
| Dilatation | 4 | 2022 | 58 | 1.600 |
Why?
|
| Hearing Tests | 12 | 2021 | 70 | 1.540 |
Why?
|
| Ear, Inner | 4 | 2022 | 47 | 1.540 |
Why?
|
| Otolaryngology | 3 | 2020 | 38 | 1.500 |
Why?
|
| Humans | 92 | 2022 | 68525 | 1.450 |
Why?
|
| Child | 22 | 2022 | 6400 | 1.440 |
Why?
|
| Obesity | 6 | 2018 | 1074 | 1.430 |
Why?
|
| Deafness | 7 | 2022 | 64 | 1.360 |
Why?
|
| Prevalence | 12 | 2021 | 1609 | 1.350 |
Why?
|
| Otologic Surgical Procedures | 4 | 2021 | 23 | 1.260 |
Why?
|
| Carotid Artery, Internal | 2 | 2019 | 85 | 1.250 |
Why?
|
| Clinical Competence | 3 | 2022 | 657 | 1.200 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2017 | 35 | 1.200 |
Why?
|
| Tinnitus | 7 | 2021 | 22 | 1.200 |
Why?
|
| Male | 53 | 2021 | 37281 | 1.180 |
Why?
|
| Audiometry | 5 | 2020 | 50 | 1.160 |
Why?
|
| Treatment Outcome | 28 | 2022 | 7028 | 1.100 |
Why?
|
| Female | 49 | 2021 | 38015 | 1.100 |
Why?
|
| Neurosurgical Procedures | 3 | 2015 | 98 | 1.060 |
Why?
|
| Semicircular Canals | 3 | 2020 | 9 | 1.060 |
Why?
|
| Infant | 13 | 2021 | 2891 | 1.050 |
Why?
|
| Aged | 31 | 2021 | 14842 | 0.970 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 2022 | 9 | 0.970 |
Why?
|
| Cerebrospinal Fluid Leak | 4 | 2018 | 32 | 0.970 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2019 | 2323 | 0.900 |
Why?
|
| Video Recording | 2 | 2020 | 145 | 0.890 |
Why?
|
| Aged, 80 and over | 16 | 2021 | 4843 | 0.880 |
Why?
|
| Hearing Loss, Conductive | 3 | 2020 | 12 | 0.880 |
Why?
|
| Endolymphatic Hydrops | 1 | 2022 | 4 | 0.860 |
Why?
|
| Databases, Factual | 7 | 2020 | 621 | 0.790 |
Why?
|
| Neuroma, Acoustic | 4 | 2019 | 17 | 0.780 |
Why?
|
| Middle Aged | 34 | 2021 | 21119 | 0.770 |
Why?
|
| Postoperative Complications | 7 | 2018 | 1615 | 0.760 |
Why?
|
| Hypocalcemia | 1 | 2020 | 13 | 0.760 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 1 | 2020 | 6 | 0.760 |
Why?
|
| Vestibular Diseases | 1 | 2020 | 11 | 0.750 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2020 | 10 | 0.750 |
Why?
|
| Reoperation | 4 | 2018 | 467 | 0.740 |
Why?
|
| Mastoid | 3 | 2022 | 20 | 0.740 |
Why?
|
| Audiometry, Pure-Tone | 7 | 2022 | 96 | 0.740 |
Why?
|
| Marfan Syndrome | 1 | 2020 | 42 | 0.740 |
Why?
|
| Adult | 33 | 2022 | 21375 | 0.730 |
Why?
|
| Vertigo | 5 | 2020 | 24 | 0.720 |
Why?
|
| Turner Syndrome | 1 | 2019 | 10 | 0.720 |
Why?
|
| Labyrinth Diseases | 1 | 2019 | 3 | 0.720 |
Why?
|
| Cochlear Diseases | 1 | 2019 | 2 | 0.720 |
Why?
|
| Hearing Loss, Unilateral | 2 | 2020 | 7 | 0.720 |
Why?
|
| Malnutrition | 1 | 2020 | 28 | 0.710 |
Why?
|
| Migraine Disorders | 1 | 2020 | 66 | 0.710 |
Why?
|
| Otitis Externa | 2 | 2018 | 14 | 0.700 |
Why?
|
| Pregnancy in Diabetics | 1 | 2020 | 70 | 0.700 |
Why?
|
| Sickle Cell Trait | 1 | 2019 | 24 | 0.680 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 693 | 0.660 |
Why?
|
| Kartagener Syndrome | 1 | 2017 | 3 | 0.640 |
Why?
|
| Cerebral Palsy | 1 | 2018 | 24 | 0.630 |
Why?
|
| Propionibacterium acnes | 1 | 2017 | 10 | 0.630 |
Why?
|
| Dwarfism, Pituitary | 1 | 2017 | 4 | 0.620 |
Why?
|
| Bone Density | 1 | 2018 | 159 | 0.620 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 292 | 0.610 |
Why?
|
| Gastroesophageal Reflux | 1 | 2020 | 318 | 0.610 |
Why?
|
| Anus, Imperforate | 1 | 2017 | 3 | 0.610 |
Why?
|
| Ectodermal Dysplasia | 1 | 2017 | 8 | 0.600 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2017 | 33 | 0.600 |
Why?
|
| Growth Disorders | 1 | 2017 | 21 | 0.600 |
Why?
|
| Propionibacterium | 1 | 2016 | 1 | 0.600 |
Why?
|
| Nose | 1 | 2017 | 36 | 0.600 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 176 | 0.600 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 13 | 0.600 |
Why?
|
| Hearing Aids | 3 | 2022 | 34 | 0.590 |
Why?
|
| Hypothyroidism | 1 | 2017 | 24 | 0.590 |
Why?
|
| Young Adult | 15 | 2021 | 5708 | 0.590 |
Why?
|
| Duane Retraction Syndrome | 1 | 2016 | 5 | 0.580 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2017 | 62 | 0.580 |
Why?
|
| Pancreatic Diseases | 1 | 2017 | 66 | 0.580 |
Why?
|
| Otitis Media | 3 | 2022 | 35 | 0.580 |
Why?
|
| Quality Improvement | 3 | 2021 | 413 | 0.580 |
Why?
|
| Hearing | 4 | 2021 | 133 | 0.580 |
Why?
|
| Health Status Disparities | 1 | 2020 | 326 | 0.580 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2016 | 13 | 0.570 |
Why?
|
| Down Syndrome | 1 | 2017 | 119 | 0.570 |
Why?
|
| Aneurysm, False | 1 | 2016 | 60 | 0.560 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 378 | 0.560 |
Why?
|
| Adolescent | 12 | 2021 | 8903 | 0.560 |
Why?
|
| Cystic Fibrosis | 2 | 2017 | 283 | 0.550 |
Why?
|
| Intellectual Disability | 1 | 2017 | 114 | 0.540 |
Why?
|
| Aspergillosis | 1 | 2015 | 20 | 0.540 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 47 | 0.530 |
Why?
|
| Round Window, Ear | 1 | 2015 | 8 | 0.530 |
Why?
|
| Ear | 1 | 2015 | 12 | 0.520 |
Why?
|
| Elective Surgical Procedures | 1 | 2015 | 95 | 0.520 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 1851 | 0.520 |
Why?
|
| Pseudomonas Infections | 1 | 2015 | 83 | 0.510 |
Why?
|
| Hearing Loss, Sudden | 1 | 2014 | 4 | 0.510 |
Why?
|
| Endolymphatic Sac | 1 | 2014 | 6 | 0.500 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 756 | 0.490 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 55 | 0.490 |
Why?
|
| Hearing Loss, Bilateral | 4 | 2022 | 13 | 0.480 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 156 | 0.480 |
Why?
|
| Disease Progression | 4 | 2019 | 1037 | 0.480 |
Why?
|
| Diabetes Complications | 1 | 2015 | 249 | 0.470 |
Why?
|
| Length of Stay | 2 | 2018 | 780 | 0.450 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 186 | 0.450 |
Why?
|
| Hallermann's Syndrome | 1 | 2012 | 1 | 0.450 |
Why?
|
| Depression | 1 | 2020 | 942 | 0.440 |
Why?
|
| Prospective Studies | 9 | 2022 | 3702 | 0.440 |
Why?
|
| Risk Factors | 7 | 2020 | 5719 | 0.440 |
Why?
|
| Ear Canal | 1 | 2012 | 24 | 0.440 |
Why?
|
| Ear Neoplasms | 1 | 2012 | 13 | 0.430 |
Why?
|
| Facial Nerve | 2 | 2017 | 25 | 0.430 |
Why?
|
| Plasmacytoma | 1 | 2012 | 15 | 0.430 |
Why?
|
| United States | 8 | 2020 | 7335 | 0.430 |
Why?
|
| Skull Neoplasms | 1 | 2012 | 23 | 0.430 |
Why?
|
| Skull | 1 | 2012 | 63 | 0.430 |
Why?
|
| Comorbidity | 3 | 2020 | 1425 | 0.400 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1548 | 0.380 |
Why?
|
| Algorithms | 3 | 2016 | 1194 | 0.370 |
Why?
|
| Cochlea | 4 | 2022 | 169 | 0.360 |
Why?
|
| Auditory Threshold | 3 | 2022 | 206 | 0.350 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2020 | 114 | 0.310 |
Why?
|
| Sinusitis | 3 | 2022 | 432 | 0.300 |
Why?
|
| Speech Reception Threshold Test | 2 | 2019 | 25 | 0.300 |
Why?
|
| Chronic Disease | 4 | 2022 | 1329 | 0.300 |
Why?
|
| Age Factors | 4 | 2020 | 1860 | 0.290 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 1139 | 0.280 |
Why?
|
| Acoustic Impedance Tests | 3 | 2021 | 11 | 0.280 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2264 | 0.270 |
Why?
|
| Otosclerosis | 1 | 2004 | 2 | 0.260 |
Why?
|
| Stapes Surgery | 1 | 2004 | 3 | 0.260 |
Why?
|
| Ear, Middle | 3 | 2021 | 32 | 0.250 |
Why?
|
| Paranasal Sinuses | 2 | 2020 | 165 | 0.240 |
Why?
|
| Quality of Life | 4 | 2022 | 1515 | 0.240 |
Why?
|
| Patient Satisfaction | 4 | 2021 | 378 | 0.240 |
Why?
|
| Registries | 2 | 2018 | 730 | 0.230 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 3256 | 0.230 |
Why?
|
| Cholesteatoma | 1 | 2022 | 4 | 0.220 |
Why?
|
| Noise | 3 | 2021 | 153 | 0.220 |
Why?
|
| Congenital Hypothyroidism | 1 | 2022 | 6 | 0.210 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2021 | 33 | 0.200 |
Why?
|
| Benign Paroxysmal Positional Vertigo | 1 | 2020 | 6 | 0.190 |
Why?
|
| Otoscopy | 1 | 2020 | 3 | 0.190 |
Why?
|
| Time and Motion Studies | 1 | 2020 | 16 | 0.190 |
Why?
|
| Middle Ear Ventilation | 1 | 2020 | 7 | 0.190 |
Why?
|
| Phonetics | 2 | 2011 | 42 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2018 | 2004 | 0.190 |
Why?
|
| Dizziness | 1 | 2020 | 27 | 0.190 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2021 | 46 | 0.190 |
Why?
|
| Fundoplication | 1 | 2020 | 27 | 0.190 |
Why?
|
| Vestibule, Labyrinth | 1 | 2020 | 19 | 0.190 |
Why?
|
| Hyperbilirubinemia | 1 | 2020 | 12 | 0.180 |
Why?
|
| Asphyxia Neonatorum | 1 | 2020 | 14 | 0.180 |
Why?
|
| Esophagitis | 1 | 2020 | 45 | 0.180 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2020 | 40 | 0.180 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 68 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 2 | 2017 | 1026 | 0.180 |
Why?
|
| Models, Neurological | 2 | 2011 | 136 | 0.180 |
Why?
|
| Faculty, Medical | 1 | 2020 | 110 | 0.180 |
Why?
|
| Space Flight | 1 | 2020 | 40 | 0.180 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 142 | 0.170 |
Why?
|
| Speech | 3 | 2016 | 118 | 0.170 |
Why?
|
| Hospitals, Low-Volume | 1 | 2018 | 12 | 0.160 |
Why?
|
| Hospitals, High-Volume | 1 | 2018 | 18 | 0.160 |
Why?
|
| Neurotology | 1 | 2018 | 7 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2022 | 2222 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 2798 | 0.160 |
Why?
|
| Hearing Disorders | 1 | 2017 | 23 | 0.160 |
Why?
|
| Audiology | 1 | 2017 | 8 | 0.150 |
Why?
|
| Human Growth Hormone | 1 | 2017 | 20 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2077 | 0.150 |
Why?
|
| Operative Time | 1 | 2017 | 45 | 0.150 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 42 | 0.150 |
Why?
|
| Universities | 1 | 2018 | 191 | 0.150 |
Why?
|
| Infant, Newborn | 2 | 2020 | 2453 | 0.150 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 955 | 0.150 |
Why?
|
| Ossicular Prosthesis | 1 | 2016 | 10 | 0.150 |
Why?
|
| Speech Intelligibility | 1 | 2016 | 14 | 0.150 |
Why?
|
| Intracranial Hypertension | 1 | 2017 | 53 | 0.140 |
Why?
|
| Publishing | 1 | 2018 | 89 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2017 | 737 | 0.140 |
Why?
|
| Prosthesis Failure | 2 | 2015 | 130 | 0.140 |
Why?
|
| Cranial Fossa, Anterior | 1 | 2016 | 8 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2020 | 1341 | 0.140 |
Why?
|
| Angiography | 1 | 2016 | 194 | 0.140 |
Why?
|
| South Carolina | 2 | 2020 | 2750 | 0.140 |
Why?
|
| Facial Nerve Diseases | 1 | 2015 | 13 | 0.140 |
Why?
|
| Debridement | 1 | 2015 | 55 | 0.130 |
Why?
|
| Speech Discrimination Tests | 1 | 2014 | 17 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 333 | 0.130 |
Why?
|
| Drug Administration Routes | 1 | 2014 | 25 | 0.130 |
Why?
|
| Prednisolone | 1 | 2014 | 23 | 0.130 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 596 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 92 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2017 | 267 | 0.120 |
Why?
|
| Body Mass Index | 2 | 2016 | 866 | 0.120 |
Why?
|
| Administration, Topical | 1 | 2014 | 111 | 0.120 |
Why?
|
| Prednisone | 1 | 2014 | 104 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1046 | 0.120 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 2 | 2022 | 49 | 0.120 |
Why?
|
| Salvage Therapy | 1 | 2014 | 82 | 0.120 |
Why?
|
| Pregnancy | 1 | 2020 | 2331 | 0.120 |
Why?
|
| Methylprednisolone | 1 | 2014 | 99 | 0.120 |
Why?
|
| Dexamethasone | 1 | 2014 | 150 | 0.120 |
Why?
|
| Patient Safety | 1 | 2015 | 202 | 0.120 |
Why?
|
| Phenotype | 1 | 2016 | 946 | 0.110 |
Why?
|
| Radiography | 1 | 2014 | 572 | 0.110 |
Why?
|
| Recurrence | 1 | 2015 | 948 | 0.110 |
Why?
|
| Bone Diseases, Developmental | 1 | 2012 | 15 | 0.110 |
Why?
|
| Tympanoplasty | 2 | 2022 | 13 | 0.110 |
Why?
|
| Postoperative Period | 3 | 2021 | 238 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2018 | 561 | 0.110 |
Why?
|
| Chemoradiotherapy | 1 | 2012 | 54 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2015 | 2356 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2014 | 880 | 0.100 |
Why?
|
| Incidence | 1 | 2015 | 1582 | 0.100 |
Why?
|
| Analysis of Variance | 3 | 2010 | 1039 | 0.090 |
Why?
|
| Pressure | 2 | 2021 | 252 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 929 | 0.090 |
Why?
|
| Hospitalization | 1 | 2015 | 977 | 0.090 |
Why?
|
| Time Perception | 1 | 2008 | 9 | 0.080 |
Why?
|
| Barotrauma | 1 | 2007 | 3 | 0.080 |
Why?
|
| Pneumocephalus | 1 | 2007 | 12 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 1 | 2006 | 53 | 0.070 |
Why?
|
| Rhinitis | 1 | 2010 | 383 | 0.060 |
Why?
|
| Action Potentials | 1 | 2006 | 223 | 0.060 |
Why?
|
| Foreign-Body Migration | 1 | 2004 | 38 | 0.060 |
Why?
|
| Linear Models | 1 | 2006 | 521 | 0.060 |
Why?
|
| Encephalocele | 2 | 2017 | 30 | 0.060 |
Why?
|
| Geriatric Assessment | 1 | 2004 | 107 | 0.060 |
Why?
|
| Pseudotumor Cerebri | 2 | 2017 | 43 | 0.060 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2022 | 19 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2004 | 506 | 0.050 |
Why?
|
| Psychoacoustics | 2 | 2011 | 33 | 0.050 |
Why?
|
| Hyperemia | 1 | 2020 | 14 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2003 | 384 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 4655 | 0.050 |
Why?
|
| Valsalva Maneuver | 1 | 2019 | 10 | 0.050 |
Why?
|
| Tympanic Membrane | 1 | 2019 | 25 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 67 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 109 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 117 | 0.040 |
Why?
|
| Prognosis | 1 | 2004 | 2093 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2020 | 328 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 214 | 0.040 |
Why?
|
| Inventions | 1 | 2018 | 7 | 0.040 |
Why?
|
| SEER Program | 1 | 2019 | 150 | 0.040 |
Why?
|
| Endoscopy | 1 | 2022 | 464 | 0.040 |
Why?
|
| Morbidity | 1 | 2018 | 130 | 0.040 |
Why?
|
| Device Removal | 1 | 2018 | 100 | 0.040 |
Why?
|
| Speech Production Measurement | 1 | 2017 | 14 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2018 | 301 | 0.040 |
Why?
|
| Focus Groups | 1 | 2017 | 247 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 129 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2018 | 384 | 0.040 |
Why?
|
| Survival Rate | 1 | 2018 | 1055 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2015 | 157 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2015 | 403 | 0.030 |
Why?
|
| Pediatrics | 1 | 2015 | 341 | 0.030 |
Why?
|
| Cranial Fossa, Middle | 1 | 2010 | 8 | 0.020 |
Why?
|
| Empty Sella Syndrome | 1 | 2010 | 10 | 0.020 |
Why?
|
| Meningocele | 1 | 2010 | 12 | 0.020 |
Why?
|
| Information Theory | 1 | 2010 | 1 | 0.020 |
Why?
|
| Mathematical Concepts | 1 | 2010 | 5 | 0.020 |
Why?
|
| Psycholinguistics | 1 | 2010 | 10 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2010 | 206 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 546 | 0.020 |
Why?
|
| Time | 1 | 2008 | 57 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 785 | 0.020 |
Why?
|
| Cues | 1 | 2011 | 654 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2010 | 705 | 0.020 |
Why?
|